We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO Latin America Conference
September 4-5, 2018
BIO Investor Forum
October 17-18, 2018
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
October 17 - 18, 2018 | San Francisco, California
Martin has over 30 years of experience developing numerous antibody and small molecule drugs as CMO of two venture-funded biotechs, and as VP of Clinical Research of Aventis Behring. He is a Board-certified Hematologist and had faculty positions at University of Texas and Baylor College of Medicine. Martin has experience in all phases of drug development and regulatory agency interactions. He is an angel investor, advisor to several biotechs, and serves on philanthropic boards.
This speaker's sessions: